The global 5-hydroxytryptamine receptor market is attracting greater research interest as pharmaceutical companies explore receptor-based therapies for neurological, psychiatric, and gastrointestinal conditions. Research institutions are also investigating serotonin signaling pathways to improve the understanding of disease mechanisms and identify potential drug targets. 5-hydroxytryptamine...